Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale |
2024-12-31 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 11,146,954 9.400% |
-1,268,688 (-10.22%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 11,915,821 10.090% |
154,216 (+1.31%) |
Filing History |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Cytokinetics, Incorporated CYTK |
T. Rowe Price Investment Management, Inc. | 9,689,987 8.200% |
9,689,987 (New Position) |
Filing History |
| 2024-11-12 2:21 pm Unchanged |
2024-09-30 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 11,761,605 9.990% |
0 (Unchanged) |
Filing History |
| 2024-11-12 11:44 am Unchanged |
2024-09-30 | 13G | Cytokinetics, Incorporated CYTK |
BLACKROCK INC BLK |
15,252,905 13.000% |
0 (Unchanged) |
Filing History |
| 2024-11-12 09:55 am Sale |
2024-11-08 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 12,415,642 10.518% |
-592,141 (-4.55%) |
Filing History |
| 2024-11-04 11:17 am Purchase |
2024-09-30 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 11,761,605 9.990% |
744,716 (+6.76%) |
Filing History |
| 2024-10-23 5:04 pm Sale |
2024-09-30 | 13G | Cytokinetics, Incorporated CYTK |
BLACKROCK INC BLK |
15,252,905 13.000% |
-1,047,636 (-6.43%) |
Filing History |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 11,016,889 11.240% |
943,795 (+9.37%) |
Filing History |
| 2024-02-09 08:50 am Sale |
2024-02-08 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 13,007,783 13.265% |
-401,460 (-2.99%) |
Filing History |
| 2024-02-08 10:11 am Sale |
2023-12-29 | 13G | Cytokinetics, Incorporated CYTK |
WELLINGTON MANAGEMENT CO LLP | 6,530,884 6.660% |
-11,840 (-0.18%) |
Filing History |
| 2024-01-25 10:45 am Purchase |
2023-12-31 | 13G | Cytokinetics, Incorporated CYTK |
STATE STREET CORP STT |
5,893,358 6.010% |
848,444 (+16.82%) |
Filing History |
| 2024-01-22 2:03 pm Purchase |
2023-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BLACKROCK INC BLK |
16,300,541 16.400% |
532,667 (+3.38%) |
Filing History |
| 2023-02-10 2:11 pm Unchanged |
2022-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BLACKROCK INC BLK |
15,767,874 16.700% |
0 (Unchanged) |
Filing History |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 10,073,094 10.640% |
1,331,970 (+15.24%) |
Filing History |
| 2023-02-09 09:59 am Purchase |
2023-02-09 | 13G | Cytokinetics, Incorporated CYTK |
FMR CORP | 13,409,243 14.162% |
819,408 (+6.51%) |
Filing History |
| 2023-02-06 2:51 pm Purchase |
2022-12-30 | 13G | Cytokinetics, Incorporated CYTK |
WELLINGTON MANAGEMENT CO LLP | 6,542,724 6.910% |
6,542,724 (New Position) |
Filing History |
| 2023-02-03 09:51 am Purchase |
2022-12-31 | 13G | Cytokinetics, Incorporated CYTK |
STATE STREET CORP STT |
5,044,914 5.330% |
1,059,687 (+26.59%) |
Filing History |
| 2023-01-26 08:52 am Purchase |
2022-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BLACKROCK INC BLK |
15,767,874 16.000% |
800,557 (+5.35%) |
Filing History |
| 2023-01-20 3:00 pm Purchase |
2022-12-31 | 13G | Cytokinetics, Incorporated CYTK |
BLACKROCK INC BLK |
14,967,317 16.000% |
2,016,353 (+15.57%) |
Filing History |